BioSpace News Archive

Drug Development

Arcturus COVID-19 Vaccine Hits Mark in Phase III Trial

Arcturus Therapeutics announced positive Phase III trial results for its mRNA vaccine candidate, ARCT-154, intended to prevent COVID-19 caused by the SARS-CoV-2 virus.

April 20, 2022
·
2 min read
·
Hayley Shasteen
Elsevier Survey: Research Cooperation During COVID-19 Improved while Funding Lags

The COVID-19 pandemic has seen increased collaboration in the research community while concerns about funding for overall research projects persist, according to Elsevier.

April 20, 2022
·
2 min read
·
Geoff Herman
Drug Development

FDA’s Cancer Advisory Committee to Evaluate Safety of PI3K inhibitors

The U.S. FDA’s Oncologic Drugs Advisory Committee is holding a meeting on April 21, 2022, to discuss safety findings across the entire class of PI3K inhibitors for hematological cancers.

April 20, 2022
·
5 min read
·
Mark Terry
Drug Development

AlloVir Snags Coveted RMAT Designation For T Cell Therapy

RMAT designation means a faster, more streamlined approval process and frequent communication with FDA representatives. The FDA recently granted RMAT Designations to both Direct Bio and AlloVir.

April 20, 2022
·
3 min read
·
Hannah Chudleigh
Policy

Illumina Chief: “The Goal Should Be This Is Our Last Pandemic”

More than two years into the COVID-19 pandemic, some experts, business leaders and government agencies are starting to prep for the next potential pandemic.

April 20, 2022
·
5 min read
·
Mark Terry
Business

Former Novartis Exec Helms Newly Launched Satellite Bio

The company brings to the arena bioengineered tissues that repair, restore or replace an organ or tissue functioning, called Tissue Therapeutics.

April 20, 2022
·
2 min read
·
Hayley Shasteen
Policy

Pharma Continues to Support Ukraine as War Rages On

AbbVie, Novartis, Pfizer and other biopharma companies are ramping up support to Ukraine in the face of the continuing Russian invasion.

April 20, 2022
·
3 min read
·
Mark Terry
Job Trends

Seagen and NovoCure to Open New Manufacturing and Learning Facilities

Seagen, Inc. and NovoCure Ltd. have each announced plans to open new facilities in the coming years, expanding local employment opportunities and respective presences in the biotech industry.

April 20, 2022
·
2 min read
·
Jazmine Coltriano, MS
Cleanroom Consumables Market Analysis and Forecast by 2031

Albany NY, United States: The global cleanroom consumables market was valued over US$ 16.4 Bn in 2020 and is projected to expand at a CAGR of 0.4% from 2021 to 2031.

April 20, 2022
·
5 min read
Intraocular Lens Market: Increasing Awareness of Eye Heath and Intraocular Lens Accelerate the Market

Albany NY, United States: According to the report, the global intraocular lens market was valued at US$ 3.9 Bn in 2020 and is projected to expand at a CAGR of 4.9% from 2021 to 2028.

April 20, 2022
·
5 min read